Product NDC: | 31722-519 |
Proprietary Name: | Hydralazine Hydrochloride |
Non Proprietary Name: | Hydralazine Hydrochloride |
Active Ingredient(s): | 10 mg/1 & nbsp; Hydralazine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 31722-519 |
Labeler Name: | Camber Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040901 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100101 |
Package NDC: | 31722-519-10 |
Package Description: | 12 BOTTLE in 1 CASE (31722-519-10) > 1000 TABLET in 1 BOTTLE |
NDC Code | 31722-519-10 |
Proprietary Name | Hydralazine Hydrochloride |
Package Description | 12 BOTTLE in 1 CASE (31722-519-10) > 1000 TABLET in 1 BOTTLE |
Product NDC | 31722-519 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydralazine Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100101 |
Marketing Category Name | ANDA |
Labeler Name | Camber Pharmaceuticals |
Substance Name | HYDRALAZINE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC] |